Biointron is proud to share that we have received the 2024 Scientist.com Supplier Performance Recognition Award, for our dedication to providing high-quality drug discovery research services on this industry-renowned R&D sourcing platform.
The award is based on key performance indicators, including but not limited to:
Responsiveness: the time it takes to respond to client requests
Marketplace activity: the number of requests received/fulfilled
Customer satisfaction: star ratings posted by researchers following completed requests
With hundreds of orders completed and a 98% response rate, Biointron served researchers from more than 20 top pharmaceutical companies in 2024 on Scientist.com. Additionally, our Antibody Production and Protein Production services are recognized as top services on the platform.
This recognition reflects the hard work and dedication of the entire Biointron team, as well as the trust and support of our customers. We are honored to have contributed to the success of so many biopharma clients and remain committed to delivering outstanding service and solutions in the year ahead.
We extend our heartfelt gratitude to Scientist.com and our customers for making this achievement possible!
Learn more our services > https://www.biointron.com/services/
Introducing a new High-throughput Fully Humanized Antibody Discovery Platform with Biointron AbDrop & Cyagen HUGO-Ab! This novel approach combines microfluidic technology for single B cell antibody discovery and fully human antibody mice for a safer and more efficient approach for fully human antibody discovery, ready in as quickly as 3 months.
In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron
Biointron is proud to announce a strategic partnership with FatiAbGen, a leading biotechnology firm focused on antibody-based therapeutics. As the newly appointed Korean distributor for Biointron, FatiAbGen will be at the forefront of delivering Biointron’s products to the Korean market.